Preventing adverse drug events in hospitalized patients

OBJECTIVE: To use computerized adverse drug event (ADE) surveillance to help identify methods to reduce the number of ADEs in hospitalized patients. DESIGN: Prospective study of 79,719 hospitalized patients during a 44-month period. SETTING: LDS Hospital, a 520-bed tertiary care center affiliated with the University of Utah School of Medicine, Salt Lake City. INTERVENTION: Sequential study periods of at least one year each were compared. In the first period, data were collected but not reported to physicians, pharmacists, or nurses. In the subsequent study periods, three interventions (computerized alerts of drug allergies, standardized antibiotic administration rates, and timely physician notification of all ADEs) were made to reduce the number of type B (allergic or idiosyncratic reactions) and severe ADEs. RESULTS: In the first study period, we identified 56 type B ADEs during 120,213 patient days. During two subsequent study periods that included alerts to physicians of known drug allergies and standardized antibiotic administration rates, 8 type B events were identified during 113,237 patient days and 18 during 107,868 patient days, respectively (p < 0.002). Early notification of physicians of all confirmed ADEs regardless of severity was associated with a significant reduction of ADEs classified as severe from 41 during 113,859 patient days in the first study period to 12 during 103,071 patient days and 15 during 108,320 patient days in two subsequent study periods, respectively (p < 0.001). CONCLUSIONS: Prospective surveillance of computer-based medical records for known drug allergies and appropriate drug administration rates can reduce the number of type B ADEs. Early ADE detection and notification of physicians permit drug and dosage changes that reduce the progression of mild and moderate ADEs to more severe conditions.

This article has been cited by other articles:

				J. E. van Doormaal, P. M.L.A. van den Bemt, R. J. Zaal, A. C.G. Egberts, B. W. Lenderink, J. G.W. Kosterink, F. M. Haaijer-Ruskamp, and P. G.M. Mol The Influence that Electronic Prescribing Has on Medication Errors and Preventable Adverse Drug Events: an Interrupted Time-series Study J. Am. Med. Inform. Assoc., November 1, 2009; 16(6): 816 - 825. [Abstract] [Full Text] [PDF]

				A. K. Jha, J. Laguette, A. Seger, and D. W. Bates Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial Application J. Am. Med. Inform. Assoc., September 1, 2008; 15(5): 647 - 653. [Abstract] [Full Text] [PDF]

				Y. Ko, J. Abarca, D. C. Malone, D. C. Dare, D. Geraets, A. Houranieh, W. N. Jones, W. P. Nichol, G. P. Schepers, and M. Wilhardt Practitioners' Views on Computerized Drug-Drug Interaction Alerts in the VA System J. Am. Med. Inform. Assoc., January 1, 2007; 14(1): 56 - 64. [Abstract] [Full Text] [PDF]

				P. E. Johnston, D. J. France, D. W. Byrne, H. J. Murff, B. Lee, R. A. Stiles, and T. Speroff Assessment of adverse drug events among patients in a tertiary care medical center Am. J. Health Syst. Pharm., November 15, 2006; 63(22): 2218 - 2227. [Abstract] [Full Text] [PDF]

				J. Le, T. Nguyen, A. V. Law, and J. Hodding Adverse Drug Reactions Among Children Over a 10-Year Period Pediatrics, August 1, 2006; 118(2): 555 - 562. [Abstract] [Full Text] [PDF]

				P M Kilbridge, E M Welebob, and D C Classen Development of the Leapfrog methodology for evaluating hospital implemented inpatient computerized physician order entry systems. Qual. Saf. Health Care, April 1, 2006; 15(2): 81 - 84. [Abstract] [Full Text] [PDF]

				C. E. Hartis, M. O. Gum, and J. W. Lederer Jr. Use of specific indicators to detect warfarin-related adverse events Am. J. Health Syst. Pharm., August 15, 2005; 62(16): 1683 - 1688. [Abstract] [Full Text] [PDF]

				R S. Evans, J. F Lloyd, G. J Stoddard, J. R Nebeker, and M. H Samore Risk Factors for Adverse Drug Events: A 10-Year Analysis Ann. Pharmacother., July 1, 2005; 39(7): 1161 - 1168. [Abstract] [Full Text] [PDF]

				J.-L. Vincent, M. M. Wilkes, and R. J. Navickis Safety of human albumin--serious adverse events reported worldwide in 1998-2000{dagger} Br. J. Anaesth., November 1, 2003; 91(5): 625 - 630. [Abstract] [Full Text] [PDF]

				N. M. A. LaPointe and J. G. Jollis Medication Errors in Hospitalized Cardiovascular Patients Arch Intern Med, June 23, 2003; 163(12): 1461 - 1466. [Abstract] [Full Text] [PDF]

				D. W. Bates, R. S. Evans, H. Murff, P. D. Stetson, L. Pizziferri, and G. Hripcsak Detecting Adverse Events Using Information Technology J. Am. Med. Inform. Assoc., March 1, 2003; 10(2): 115 - 128. [Abstract] [Full Text] [PDF]

				M. T. Holdsworth, R. E. Fichtl, M. Behta, D. W. Raisch, E. Mendez-Rico, A. Adams, M. Greifer, S. Bostwick, and B. M. Greenwald Incidence and Impact of Adverse Drug Events in Pediatric Inpatients Arch Pediatr Adolesc Med, January 1, 2003; 157(1): 60 - 65. [Abstract] [Full Text] [PDF]

				J. M. Rothschild, F. A. Federico, T. K. Gandhi, R. Kaushal, D. H. Williams, and D. W. Bates Analysis of Medication-Related Malpractice Claims: Causes, Preventability, and Costs Arch Intern Med, November 25, 2002; 162(21): 2414 - 2420. [Abstract] [Full Text] [PDF]

				H. J. Murff, A. J. Forster, J. F. Peterson, J. M. Fiskio, H. L. Heiman, and D. W. Bates Electronically Screening Discharge Summaries for Adverse Medical Events J. Am. Med. Inform. Assoc., November 1, 2002; 9(90061): S50 - 51. [Full Text] [PDF]

				J. Weiss, S. Krebs, C. Hoffmann, U. Werner, A. Neubert, K. Brune, and W. Rascher Survey of Adverse Drug Reactions on a Pediatric Ward: A Strategy for Early and Detailed Detection Pediatrics, August 1, 2002; 110(2): 254 - 257. [Abstract] [Full Text] [PDF]

				H. J. Murff and J. Kannry Physician Satisfaction with Two Order Entry Systems J. Am. Med. Inform. Assoc., September 1, 2001; 8(5): 499 - 511. [Abstract] [Full Text] [PDF]

				D. W. Bates A 40-Year-Old Woman Who Noticed a Medication Error JAMA, June 27, 2001; 285(24): 3134 - 3140. [Full Text] [PDF]

				D. W. Bates, J. M. Teich, J. Lee, D. Seger, G. J. Kuperman, N. Ma'Luf, D. Boyle, and L. Leape The Impact of Computerized Physician Order Entry on Medication Error Prevention J. Am. Med. Inform. Assoc., July 1, 1999; 6(4): 313 - 321. [Abstract] [Full Text] [PDF]

				K. Fremont-Smith, G. R. Kravitz, T. Bush, R. Hanzlick, P. B. Baker, G. M. Hutchins, K.-K. Hui, J. Lazarou, B. H. Pomeranz, P. N. Corey, et al. Adverse Drug Reactions in Hospitalized Patients JAMA, November 25, 1998; 280(20): 1741 - 1741. [Full Text] [PDF]

				D. W. Bates, L. L. Leape, D. J. Cullen, N. Laird, L. A. Petersen, J. M. Teich, E. Burdick, M. Hickey, S. Kleefield, B. Shea, et al. Effect of Computerized Physician Order Entry and a Team Intervention on Prevention of Serious Medication Errors JAMA, October 21, 1998; 280(15): 1311 - 1316. [Abstract] [Full Text] [PDF]

				R. A. Raschke, B. Gollihare, T. A. Wunderlich, J. R. Guidry, A. I. Leibowitz, J. C. Peirce, L. Lemelson, M. A. Heisler, and C. Susong A Computer Alert System to Prevent Injury From Adverse Drug Events: Development and Evaluation in a Community Teaching Hospital JAMA, October 21, 1998; 280(15): 1317 - 1320. [Abstract] [Full Text] [PDF]

				J. Lazarou, B. H. Pomeranz, and P. N. Corey Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies JAMA, April 15, 1998; 279(15): 1200 - 1205. [Abstract] [Full Text] [PDF]

				D. C. Classen, S. L. Pestotnik, R. S. Evans, J. F. Lloyd, and J. P. Burke Adverse Drug Events in Hospitalized Patients: Excess Length of Stay, Extra Costs, and Attributable Mortality JAMA, January 22, 1997; 277(4): 301 - 306. [Abstract] [PDF]

				D. W. Bates, D. J. Cullen, N. Laird, L. A. Petersen, S. D. Small, D. Servi, G. Laffel, B. J. Sweitzer, B. F. Shea, R. Hallisey, et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention JAMA, July 5, 1995; 274(1): 29 - 34. [Abstract] [PDF]

				D. A. B. Lindberg and B. L. Humphreys Computers in Medicine JAMA, June 7, 1995; 273(21): 1667 - 1668. [Abstract] [PDF]